Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04721717 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Final enrollment: 95 participants (planned 160) · Primary completion date changed from estimate of Mar 28, 2027 to Apr 4, 2025 · Eligibility criteria expanded, about 7 words · 4 more Show 7 more changesShow less
    • Final enrollment: 95 participants (planned 160)
    • Primary completion date changed from estimate of Mar 28, 2027 to Apr 4, 2025
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 2 of 4 entries
    • Site details revised
    • Collaborators expanded, about 9 words
    • Publications: details revised at 2 of 2 entries
  2. Re-verified, no change to tracked fieldsv10
  3. Primary and study completion dates: Mar 28, 2025 to Mar 28, 2027v9
  4. Eligibility criteria expanded, about 7 words Secondary endpoints: 1 to 4v8 Show 1 more changeShow less
    • Secondary endpoints: 1 to 4

    See this version in full on ClinicalTrials.gov ↗

  5. Primary endpoints: 10 to 11v7 See this version in full on ClinicalTrials.gov ↗
Show 5 earlier versionsHide 5 earlier versions
  1. Enrollment target: 75 to 160 Eligibility criteria expanded, about 2 words · Secondary endpoints expanded, about 2 wordsv6 Show 2 more changesShow less
    • Eligibility criteria expanded, about 2 words
    • Secondary endpoints expanded, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  2. Enrollment target: 25 to 75 Primary and study completion dates: Mar 28, 2022 to Mar 28, 2025 · Trial status: Completed to Recruiting · Site details revisedv5 Show 3 more changesShow less
    • Primary and study completion dates: Mar 28, 2022 to Mar 28, 2025
    • Trial status: Completed to Recruiting
    • Site details revised
  3. Trial status: Recruiting to Completed Enrollment target: estimated 36 to confirmed 25 · Primary and study completion dates changed from estimate of Sep 1, 2022 to Mar 28, 2022 · Site details revisedv4 Show 3 more changesShow less
    • Enrollment target: estimated 36 to confirmed 25
    • Primary and study completion dates changed from estimate of Sep 1, 2022 to Mar 28, 2022
    • Site details revised
  4. Primary completion date: Mar 1, 2022 to Sep 1, 2022v3
  5. Primary completion date: Jul 1, 2021 to Mar 1, 2022 Start date: Jul 1, 2020 to Sep 1, 2020 · Completion date: Jul 1, 2021 to Sep 1, 2022v2 Show 2 more changesShow less
    • Start date: Jul 1, 2020 to Sep 1, 2020
    • Completion date: Jul 1, 2021 to Sep 1, 2022
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The UAB Institute for Arts In Medicine (AIM) is currently implementing an expressive emotional writing pilot project for adults with paralysis caused by neurological conditions such as traumatic head or spinal cord injury.
Trial Details
NCT Number NCT04721717
Lead Sponsor University of Alabama at Birmingham
Collaborators: Christopher Reeve Paralysis Foundation, The Craig H. Neilsen Foundation
Conditions Spinal Cord Injuries, Multiple Sclerosis, Transverse Myelitis, Amyotrophic Lateral Sclerosis
Enrollment 95 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov